Male breast cancer wrong statement is
## Core Concept
Male breast cancer is a rare malignancy that accounts for about 1% of all breast cancer cases. It shares many similarities with female breast cancer in terms of pathology and treatment approaches. However, there are distinct differences in risk factors, presentation, and epidemiology.
## Why the Correct Answer is Right
The correct answer, although not directly provided, needs to be evaluated based on common facts about male breast cancer. Typically, male breast cancer is more commonly associated with **BRCA2** gene mutations, tends to occur at an older age, and often presents with **nipple discharge** or a palpable mass.
## Why Each Wrong Option is Incorrect
- **Option A:** Without specific details on option A, we can't directly address its inaccuracies. However, if it suggests that male breast cancer is more common in younger men, this would be incorrect as it typically affects older men.
- **Option B:** If option B mentions a strong association with **hormonal imbalance** without specifying the type, this could be misleading. Male breast cancer is indeed hormone receptor-positive, particularly **estrogen receptor-positive**.
- **Option C:** If option C states that male breast cancer has a **better prognosis** than female breast cancer when detected at a similar stage, this statement could be considered generally correct, making it not the wrong statement we're looking for.
- **Option D:** If option D suggests that **gynecomastia** is a risk factor for male breast cancer, while gynecomastia itself isn't a direct risk factor, conditions leading to it might indicate hormonal imbalances which are relevant.
## Clinical Pearl / High-Yield Fact
A key point to remember is that male breast cancer often presents at a more advanced stage than female breast cancer, partly because men are less likely to self-examine or seek medical attention early. A classic clinical correlation is the association of male breast cancer with **BRCA2 mutations**, and these patients have a higher risk of bilateral breast cancer.
## Correct Answer: D.